Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy

Bibliography

• Lloyd-Jones D, Adams RJ, Brown TM et al. Executive summary: heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation 121, 948–954 (2010)
   Google Scholar
• British Heart Foundation Health Promotion Research Group; Health Economics Research Centre. European Cardiovascular Disease Statistics Edition. Department of Public Health, University of Oxford, UK
   Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143–3421 (2002)
   Google Scholar
• Constantinides P. Plaque hemorrhages, their genesis and their role in supra-plaque thrombosis and atherogenesis. In: Pathobiology of the Human Atherosclerotic Plaque. Glagov S, Newman WP, Schaffer SA (Eds). Springer- Verlag, NY, USA, 393–411 (1998)
   Google Scholar
• Tracey RE, Devaney K, Kissling G. Characteristics of the plaque under a coronary thrombus. Virchows Arch. A Pathol. Anat. Histopathol. 405, 411–427 (1985)
   Google Scholar
• Lendon CL, Davies MJ, Born GVR et al. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 87, 87–90 (1991)
   Google Scholar
• Davies MJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94, 2013–2020 (1996)
   Google Scholar
• van der Wal AC, Becker AE, van der Loos CM et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89, 36–44 (1994)
   Google Scholar
• Moreno PR, Falk E, Palacios IF et al. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 90, 775–778 (1994)
   Google Scholar
• Brown BG, Hillger LA, Zhao XQ et al. A maximum confidence strategy for measuring progression and regression of coronary artery disease in clinical trials. Circulation 87(Suppl. II), 66–73 (1993)
   Google Scholar
• Wasserman BA, Haacke EM, Li D. Carotid plaque formation and its evaluation with angiography, ultrasound, and MR angiography. J. Magn. Reson. Imaging 4, 515–527 (1994)
   Google Scholar
• Auperin A, Berr C, Bonithon-Kopp C et al. Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59–71 year-olds. The EVA Study Group. Stroke 27, 1290–1295 (1996)
   Google Scholar
• O'Leary DH, Polak JF, Kronmal RA et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340(1), 14–22 (1999)
   Google Scholar
• Dillon EH, van Leeuwen MS, Fernandez MA et al. CT angiography: application to the evaluation of carotid artery stenosis. Radiology 189, 211–229 (1993)
   Google Scholar
• Fayad ZA, Fuster V, Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann. NY Acad. Sci. 902, 173–186 (2000)
   Google Scholar
• Shinnar M, Fallon JT, Wehrli S et al. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler. Thromb. Vasc. Biol. 19, 2756–2761 (1999)
   Google Scholar
• Yuan C, Mitsumori LM, Ferguson MS et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104, 2051–2056 (2001)
   Google Scholar
• Mitsumori LM, Hatsukami TS, Ferguson MS et al. In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques. J. Magn. Reson. Imaging 17, 410–420 (2003)
   Google Scholar
• Cappendijk VC et al. Assessment of human atherosclerotic carotid plaque components with multisequence MR imaging: initial experience. Radiology 234, 487–492 (2005)
   Google Scholar
• Saam T, Cai JM, Cai YQ, et al. Carotid plaque composition differs between ethno-racial groups: an MRI pilot study comparing mainland Chinese and American caucasian patients. Arterioscler. Thromb. Vasc. Biol. 25, 611–616 (2005)
   Google Scholar
• Clarke SE, Hammond RR, Mitchell JR et al. Quantitative assessment of carotid plaque composition using multicontrast MRI and registered histology. Magn. Reson. Med. 50, 1199–1208 (2003)
   Google Scholar
• Cai JM, Hatsukami TS, Ferguson MS et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 106, 1368–1373 (2002)
   Google Scholar
• Takaya N, Cai J, Ferguson MS et al. Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J. Magn. Reson. Imaging 24, 203–210 (2006)
   Google Scholar
• Cai JM, Hatsukami TS, Ferguson MS et al. In vivo quantitative measurement of intact fibrous cap and lipid rich necrotic core size in atherosclerotic carotid plaque: a comparison of high resolution contrast enhanced MRI and histology. Circulation 112, 3437–3444 (2005)
   Google Scholar
• Sata M, Saiura A, Kunisato A et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8, 403–409 (2002)
   Google Scholar
• Podrez EA, Febbraio M, Sheibani N et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105, 1095–1108 (2000)
   Google Scholar
• Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108, 785–791 (2001)
   Google Scholar
• Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110, 905–911 (2002)
   Google Scholar
• Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J. Lipid Res. 23, 97–104 (1982)
   Google Scholar
• Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid Res. 43, 1363–1379 (2002)
   Google Scholar
• Krauss RM. Lipoprotein subfractions and cardiovascular disease risk. Curr. Opin Lipidol. 4, 305–311 (2010)
   Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79(1), 8–15 (1989)
   Google Scholar
• Rothblat GH, de la Llera-Moya M, Atger V, Kellner-Weibel G, Williams DL, Phillips MC. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40, 781–796 (1999)
   Google Scholar
• Ghosh S, Zhao B, Bie J et al. Macrophage cholesteryl ester mobilization and atherosclerosis. Vascul. Pharmacol. 52(1–2), 1–10 (2010)
   Google Scholar
• Kennedy MA, Barrera GC, Nakamura K et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1(2), 121–131 (2005)
   Google Scholar
• Wang N, Lan D, Chen W et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl Acad. Sci. USA 101(26), 9774–9779 (2004)
   Google Scholar
• Su YR, Ishiguro H, Major AS et al. Macrophage apolipoprotein A?I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters. Mol. Ther. 8(4), 576–583 (2003)
   Google Scholar
• Vaughan AM, Oram JF. ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. J. Biol. Chem. 280(34), 30150–30157 (2005)
   Google Scholar
• Nakamura K, Kennedy MA, Baldan A et al. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J. Biol. Chem. 279(44), 45980–45989 (2004)
   Google Scholar
• Duffy D, Rader DJ. Update on strategies to increase HDL quantity and function. Nat. Rev. Cardiol. 6, 455–463 (2009)
   Google Scholar
• Vaisar T, Pennathur S, Green PS et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117, 746–756 (2007)
   Google Scholar
• Khera AV, Cuchel M, de la Lioera-Moya M et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364, 127–135 (2011)
   Google Scholar
• Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001)
   Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA 288, 2709–2716 (2002)
   Google Scholar
• Zhao XQ, Krasuski RA, Baer J et al. Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS). Am. J. Cardiol. 104(11), 1457–1464 (2009)
   Google Scholar
• Berliner JA, Navab M, Fogelman AM et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91, 2488–2496 (1995)
   Google Scholar
• Tsao PS, Wang B, Buitrago R et al. Nitric oxide regulates monocyte chemotactic protein?1. Circulation 96, 934–940 (1997)
   Google Scholar
• Gawaz M, Neumann FJ, Dickfeld T et al. Activated platelets induce monocyte chemotactic protein?1 secretion and surface expression of intercellular adhesion molecule?1 on endothelial cells. Circulation 98, 1164–1171 (1998)
   Google Scholar
• Takahashi M, Kitagawa S, Masuyama JI et al. Human monocyte-endothelial cell interaction induces synthesis of granulocyte-macrophage colony-stimulating factor. Circulation 93, 1185–1193 (1996)
   Google Scholar
• Rajavashisth T, Qiao JH, Tripathi S et al. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptordeficient mice. J. Clin. Invest. 101, 2702–2710 (1998)
   Google Scholar
• Szmitko PE, Wang CH, Weisel RD et al. New markers of inflammation and endothelial cell activation: part I. Circulation 108, 1917–1923 (2003)
   Google Scholar
• Rectenwald JE, Moldawer LL, Huber TS et al. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102, 1697–1702 (2000)
   Google Scholar
• Brizzi MF, Formato L, Dentelli P et al. Interleukin?3 stimulates migration and proliferation of vascular smooth muscle cells: a potential role in atherogenesis. Circulation 103, 549–554 (2001)
   Google Scholar
• Simonini A, Moscucci M, Muller DW et al. IL?8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 101, 1519–1526 (2000)
   Google Scholar
• Li H, Freeman MW, Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J. Clin. Invest. 95, 122–133 (1995)
   Google Scholar
• Kaartinen M, Penttilä A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 94, 2787–2792 (1996)
   Google Scholar
• Tintut Y, Patel J, Parhami F et al. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102, 2636–2642 (2000)
   Google Scholar
• Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 105, 1135–1143 (2002)
   Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N. Eng. J. Med. 340(2), 115–126 (2003)
   Google Scholar
• Libby P, Geng YJ, Aikawa M et al. Macrophages and atherosclerotic plaque stability. Curr. Opin Lipidol. 7, 330–335 (1996)
   Google Scholar
• Farb A, Burke AP, Tang AL et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 93(7), 1354–1363 (1996)
   Google Scholar
• Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 92, 657–671 (1995)
   Google Scholar
• Littlewood TD, Bennett MR. Apoptotic cell death in atherosclerosis. Curr. Opin Lipidol. 14, 469–475 (2003)
   Google Scholar
• Falk E. Pathogenesis of atherosclerosis. J. Am. Coll. Cardiol. 47, C7–C12 (2006)
   Google Scholar
• Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc. Res. 59, 812–823 (2003)
   Google Scholar
• Virmani R, Ladich ER, Burke AP et al. Histopathology of carotid atherosclerotic disease. Neurosurgery 59, S219–S227 (2006)
   Google Scholar
• Kolodgie FD, Gold HK, Burke AP et al. Intraplaque hemorrhage and progression of coronary atheroma. N. Engl. J. Med. 349, 2316–2325 (2003)
   Google Scholar
• Kolodgie FD, Burke AP, Nakazawa G et al. Free cholesterol in atherosclerotic plaques: where does it come from? Curr. Opin Lipidol. 18, 500–507 (2007)
   Google Scholar
• Takaya N, Yuan C, Chu B et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 111, 2768–2775 (2005)
   Google Scholar
• Takaya N, Yuan C, Chu B et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI – initial results. Stroke 37, 818–823 (2006)
   Google Scholar
• Singh N, Moody AR, Gladstone DJ et al. Moderate carotid artery stenosis: MRI depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology 252, 502–508 (2009)
   Google Scholar
• Altaf N, MacSweeney ST, Gladman J et al. Carotid intraplaque hemorrhage predicts recurrent symptoms in patients with high-grade carotid stenosis. Stroke 38, 1633–1635 (2007)
   Google Scholar
• Jeziorska M, Woolley DE. Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. Hum. Pathol. 30, 919–925 (1999)
   Google Scholar
• Battegay EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J. Mol. Bio. 73, 333–346 (1995)
   Google Scholar
• O'Brien KD, McDonald TO, Chait A et al. Neovascular expression of E?selectin, intercellular adhesion molecule?1, and vascular cell adhesion molecule?1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93, 672–682 (1996)
   Google Scholar
• Demarco JK, Ota H, Underhill HR et al. MR carotid plaque imaging and contrastenhanced MR angiography identifies lesions associated with recent ipsilateral thromboembolic symptoms: an in vivo study at 3T. AJNR Am. J. Neuroradiol. 31, 1395–1402 (2010)
   Google Scholar
• Chu B, Ferguson MS, Chen H et al. Magnetic resonance imaging features of the disruptionprone and the disrupted carotid plaque. JACC Cardiovasc. Imaging 2, 883–896 (2009)
   Google Scholar
• Luo Y, Polissar N, Han C et al. Accuracy and uniqueness of three in vivo measurements of atherosclerotic carotid plaque morphology with black blood MRI. Magn. Reson. Med. 50, 75–82 (2003)
   Google Scholar
• Saam T, Ferguson MS, Yarnykh VL et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler. Thromb. Vasc. Biol. 25, 234–239 (2005).Establishes the ability of MRI to characterize a wide variety of plaque features in vivo against a histological standard
   Google Scholar
• Wasserman BA, Smith WI, Trout HH 3rd, Cannon RO 3rd, Balaban RS, Arai AE. Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology 223, 566–573 (2002)
   Google Scholar
• Liu F, Xu D, Ferguson MS, Chu B et al. Automated in vivo segmentation of carotid plaque MRI with morphology-enhanced probability maps. Magn. Reson. Med. 55, 659–668 (2006)
   Google Scholar
• Chu B, Kampschulte A, Ferguson MS et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke 35, 1079–1084 (2004)
   Google Scholar
• Qiao Y, Etesami M, Malhotra S et al. Identification of intraplaque hemorrhage on MR angiography images: a comparison of contrast-enhanced mask and time-of-flight techniques. AJNR Am. J. Neuroradiol. 32, 454–459 (2011)
   Google Scholar
• Moody AR, Murphy RE, Morgan PS et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 107, 3047–3052 (2003)
   Google Scholar
• Ota H, Yarnykh VL, Ferguson MS et al. Carotid intraplaque hemorrhage imaging at 3.0-T MR imaging: comparison of the diagnostic performance of three T1-weighted sequences. Radiology 254, 551–563 (2010)
   Google Scholar
• Wang J, Ferguson MS, Balu N et al. Improved carotid intraplaque hemorrhage imaging using a slab-selective phase-sensitive inversion-recovery (SPI) sequence. Magn. Reson. Med. 64, 1332–1340 (2010)
   Google Scholar
• Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J. Magn. Reson. Imaging 16, 407–422 (2002)
   Google Scholar
• Gaffney K, Cookson J, Blake D et al. Quantification of rheumatoid synovitis by magnetic resonance imaging. Arthritis Rheum. 38, 1610–1617 (1995)
   Google Scholar
• Semelka RC, Chung JJ, Hussain SM et al. Chronic hepatitis: Correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histophathology initial experience. J. Magn. Reson. Imaging 13, 385–391 (2001)
   Google Scholar
• Kerwin W, Hooker A, Spilker M et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107, 851–856 (2003)
   Google Scholar
• Kerwin WS, O'Brien KD, Ferguson MS et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 241, 459–468 (2006). Establishes dynamic contrast-enhanced MRI as a technique to examine neovasculature and inflammation, and relates findings to HDL
   Google Scholar
• Trivedi RA, U-King-Im JM, Graves MJ et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 35, 1631–1635 (2004)
   Google Scholar
• Desai MY, Rodriguez A, Wasserman BA et al. Association of cholesterol subfractions and carotid lipid core measured by MRI. Arterioscler. Thromb. Vasc. Biol. 25(6), e110–e111 (2005)
   Google Scholar
• Phan BA, Chu B, Polissar N et al. Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging. Int. J. Cardiovasc. Imaging 23(3), 337–342 (2007)
   Google Scholar
• Kerwin WS, Oikawa M, Yuan C et al. MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn. Reson. Med. 59, 507–514 (2008)
   Google Scholar
• Zhao XQ, Chun Y, Hatsukami TS et al. Effects of intensive lipid-lowering therapy on carotid atherosclerotic plaque composition in vivo by MRI: a case-control study. Arterioscler. Thromb. Vasc. Biol. 21, 1623–1629 (2001)
   Google Scholar
• Saam T, Yuan C, Chu B et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis 194, e34–e42 (2007). Natural history study relating general statin use to rate of progression
   Google Scholar
• Underhill HR, Yuan C, Yarnykh VL et al. Arterial remodeling in subclinical carotid artery disease. JACC Cardiovasc. Imaging 2, 1381–1389 (2009)
   Google Scholar
• Corti R, Fayad ZA, Fuster V et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104, 249–252 (2001)
   Google Scholar
• Corti R, Fuster V, Fayad ZA et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106, 2884–2887 (2002). Lipid-lowering therapy induces plaque regression as assessed by high-resolution MRI
   Google Scholar
• Parolini C, Marchesi M, Lorenzon P et al. Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-IMilano/1- palmitoyl-2-oleoyl phosphatidylcholine complex) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging. J. Am. Coll. Cardiol. 51, 1098–1103 (2008)
   Google Scholar
• Tall AR. Plasma cholesterol ester transfer protein. J. Lipid Res. 34, 1255–1274 (1993)
   Google Scholar
• Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochem. Biophys. Acta 1215, 209–236 (1994)
   Google Scholar
• Brown ML, Inazu A, Hesler CB et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342, 448–451 (1989)
   Google Scholar
• Marotti KR, Castle CK, Boyle TP et al. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364, 73–75 (1993)
   Google Scholar
• Quinet E, Tall AR, Ramakrishnan R et al. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J. Clin. Invest. 87, 1559–1566. (1991)
   Google Scholar
• Bhatnagar D, Durrington PN, Channon KM, Prais H, Mackness MI. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 98, 25–32 (1993)
   Google Scholar
• Bruce C, Chouinard RA, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu. Rev. Nutr. 18, 297–330 (1998)
   Google Scholar
• Fielding CJ, Havel RJ. Cholesteryl ester transfer proteins: friend or foe? J. Clin. Invest. 97, 2687–2688 (1996)
   Google Scholar
• Hayek T, Masucci-Magoulas L, Jiang X. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest. 96, 2071–2074 (1995)
   Google Scholar
• Zhong S, Sharp DS, Grove JS et al. Increased coronary heart disease in Japanese–American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97, 2917–2923 (1996)
   Google Scholar
• Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 6, 211–228 (1995)
   Google Scholar
• Fayad ZA, Mani V, Woodward M et al.; dal-PLAQUE Investigators. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 378, 1547–1549 (2011). Plaque area reduction associated with dalcetrapib (a CETP inhibitor)
   Google Scholar
• Clarkson TB, Bond MG, Bullock BC et al. A study of atherosclerosis regression in Macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl. Exp. Mol. Pathol. 34, 345–368 (1981). 115 Armstrong ML, Megan MB. Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets. Circ. Res. 30, 675–680 (1972)
   Google Scholar
• Small DM, Bond MG, Waugh D et al. Physiochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J. Clin. Invest. 73, 1590–1605 (1984)
   Google Scholar
• Armstrong MC, Megan MB. Arterial fibrous protein in cynomolygous monkeys after atherogenic and regression diets. Circ. Res. 36, 256–261 (1975)
   Google Scholar
• Crisby M, Nordin-Fredriksson G, Shah PK et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103, 926–933 (2001)
   Google Scholar
• Zhao XQ, Phan B, Chu B et al. Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study. Am. Heart J. 154, 239–246 (2007)
   Google Scholar
• Zhao XQ, Dong L, Hatsukami T et al. MR imaging of carotid plaque composition during lipid-lowering therapy a prospectiv assessment of effect and time course. JACC Cardiovasc. Imaging 4, 977–986 (2011). Intensive lipid therapy depletes plaque lipid content. This establishes the plaque lipid depletion time-course over 3 years
   Google Scholar
• Underhill HR, Yuan C, Zhao XQ et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a highresolution magnetic resonance imaging trial. Am. Heart J. 155, 584.e1–8 (2008). Aggressive LDL lowering decreases plaque lipid content
   Google Scholar
• Tang TY, Howarth SP, Miller SR et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophages Activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J. Am. Coll. Cardiol. 53, 2039–2050 (2009). Use of ultrasmall particles of iron oxides to monitor macrophage changes in response to statin therapy
   Google Scholar
• Dong L, Kerwin WS, Chen H et al. Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum – evaluation by using dynamic contrast-enhanced MR imaging. Radiology 260, 224–231 (2011). Use of dynamic contrast-enhanced MRI to monitor neovascular changes in response to statin therapy
   Google Scholar
• Balu N, Yarnykh VL, Chu B et al. Carotid plaque assessment using fast 3D isotropic resolution black-blood MRI. Magn. Reson. Med. 65, 627–637 (2011)
   Google Scholar
• Koktzoglou I, Li D. Diffusion-prepared segmented steady-state free precession: Application to 3D black-blood cardiovascular magnetic resonance of the thoracic aorta and carotid artery walls. J. Cardiovasc. Magn. Reson. 9, 33–42 (2007)
   Google Scholar
• Mihai G, Chung YC, Kariisa M et al. Rajagopalan S. Initial feasibility of a multi-station high resolution threedimensional dark blood angiography protocol for the assessment of peripheral arterial disease. J. Magn. Reson. Imaging 30, 785–793 (2009)
   Google Scholar
• Cormode DP, Frias JC, Ma Y et al. HDL as a contrast agent for medical imaging. Clin. Lipidol. 4(4), 493–500 (2009). Summary of future molecular imaging possibilities focused on HDL
   Google Scholar
• Frias JC, Williams KJ, Fisher EA et al. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J. Am. Chem. Soc. 126(50), 16316–16317 (2004)
   Google Scholar
• Winter PM, Morawski AM, Caruthers SD et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v) beta3-integrin-targeted nanoparticles. Circulation 108, 2270–2274 (2003)
   Google Scholar
• Burtea C, Laurent S, Murariu O et al. Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovasc. Res. 78, 148–157 (2008)
   Google Scholar
• Nahrendorf M, Jaffer FA, Kelly KA et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114, 1504–1511 (2006)
   Google Scholar
• Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337(6), 408–416 (1997).
   Google Scholar